Skip to main content
. 2009 Nov 10;3(11):e544. doi: 10.1371/journal.pntd.0000544

Table 1. Characteristics of the antigens.

Designation (GenBank accession no.) Description Evidence for protectionb Optimal adjuvant Stage of expression Percent highly, poorly, and non-immunoresponsive calvesa
IgG1c IgG2c
OoALT1 (EU573935) Secreted larval acidic protein, ‘abundant larval transcript’ [43],[44] Mouse [44],[45], human [45] Alum [45] L2, L3 [43],[44] 100, 0, 0 (0, 23, 77) 8, 92, 0 (0, 8, 92)
OoB8* (EU573934) Uncharacterised [45] Mouse, human [45] Alum [45] All [45] 67, 33, 0 (8, 23, 69) 0, 100, 0 (0, 15, 85)
OoRAL2 (EU573933) Uncharacterised [46] Moused, human [46], chimpanzee [47] Freund'sd L3, adult [46] 100, 0, 0 (23, 23, 54) 92, 8, 0 (8, 23, 69)
OoTMY1* (EU573931) Tropomyosin moiety [33] Human [33], jird [38] Freund's [38] All [33] 100, 0, 0 (54, 46, 0) 67, 33, 0 (15, 31, 54)
OoCPI (EU573930) Cysteine protease inhibitor, ‘onchocystatin’ [48],[49] Mouse, human [45] Alum [45] Egg, L3, L4, adult [48] 100, 0, 0 (23, 23, 54) 0, 100, 0 (0, 31, 69)
OoB20* (EU573937) Uncharacterised [50] Cow, jird [51] Freund's [51] Mf, L2, L3, L4 [50] 100, 0, 0 (8, 23, 69) 17, 83, 0 (0, 0, 100)
OoFAR1 (EU573932) Fatty acid retinoid-binding protein [52] Jird [53], human [40] Freund's [53] All [53] 100, 0, 0 (23, 23, 54) 100, 0, 0 (0, 31, 69)
OoFBA* (EU573936) Fructose-1,6-bisphosphate aldolase [34] Mouse [34] Freund's [34] All [34] 100, 0, 0 (31, 31, 38) 100, 0, 0 (0, 15, 85)

Notes Mf, microfilaria; L2–4, larval developmental stages.

*: These antigens represent truncated polypeptides, not full-length proteins.

a

Vaccinated calves (n = 12) received all eight antigens in separate inoculations with the respective optimal adjuvant; data in parentheses are comparative values for adjuvant-control animals that received adjuvants only (n = 13).

b

‘Mouse’ refers to the Onchocerca volvulus L3 chamber model; ‘jird’ to the filarial parasite Acanthocheilonema viteae in its natural rodent host, Meriones unguiculatus; ‘cow’ to O. lienalis in its natural host; ‘chimpanzee’ to experimental infection with O. volvulus; and ‘human’ to serological recognition by putatively immune individuals from areas endemic for O. volvulus infection.

c

Highly, poorly and non-immunoresponsive animals exhibited OD405 nm>1.0, 0.1–1.0, or <0.1 units (respectively) immediately before natural exposure to infection. Prior correction for non-specific binding was achieved by subtraction of OD405 nm for a pool of negative control sera (obtained from 6 unexposed calves that received neither antigens nor adjuvants).

d

D. Abraham, unpublished data.